课题基金 / 基金详情

Combinatorial Chemistry of Porphyrins

Combinatorial Chemistry of Porphyrins
卟啉的组合化学
批准号:
6772194
负责人:
CHARLES MICHAEL DRAIN
金额:
$11.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2008-03-31

项目摘要

项目成果

CHARLES MICHAEL DRAIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The power of combinatorial libraries for the discovery of new therapeutics and material is well recognized. The paradigm is to make directed libraries on solid supports so that an individual compound can be selected, identified, purified, and characterized. The 'winning' compound becomes the parent of a family of derivatives that are screened for enhanced activity. A problem with this approach is that solid phase libraries generally miss synergistic effects elicited by several compounds on systems with multiple targets. The reason to limit searches for synergistic effects is the exponential increase in the number of assays. Solution phase libraries are much less developed and are generally not used because the selection, identification, purification, and characterization of the lead compound(s) are much more complex. There are cases where the solution phase method affords advantages, e.g. when entire cells are targets (treatment of cancer or diseases of specific cell types, imaging of specific tissues, or eradication of bacteria). The goal is to develop the solution phase combinatorial chemistry, solution phase analytical methods, and solution phase selection schemes to identify the most promising complement of compounds which will exert the maximal synergistic effects on target cells, but development of new therapeutics is not the immediate goal. Another goal is to further understand structure-activity relationships between various functional groups and uptake by target cells. The hypothesis is: (a) in cases when there are multiple targets--e.g. whole cells--there may be synergistic relationships between several members of a combinatorial library that combine to result in significantly enhanced function compared to one compound; and (b) solution phase libraries can efficiently identify these combinations of compounds. Since both photodynamic therapy and imaging/staining are directed at certain cell populations, solution phase libraries of porphyrinoids chromophores are ideally suited to test the hypothesis for these applications. The specific aims to test the hypothesis: (1) Develop synthetic methods to make target-directed solution phase combinatorial libraries of porphyrinoids; (2) Develop analytical tools to characterize the diversity, purity, and properties of solution phase libraries of porphyrinoids; (3) Develop methods using target cells to select compounds from solution phase porphyrinoid libraries, and the means to identify them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEW THERAPEUTICS FROM PORPHYRINS, ACETOGENINS, AND THEIR CONJUGATES
  • 批准号:
    6657572
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2002
  • 负责人:
    CHARLES MICHAEL DRAIN
  • 依托单位:
NEW THERAPEUTICS FROM PORPHYRINS, ACETOGENINS, AND THEIR CONJUGATES
  • 批准号:
    6580420
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2002
  • 负责人:
    CHARLES MICHAEL DRAIN
  • 依托单位:
NEW THERAPEUTICS FROM PORPHYRINS, ACETOGENINS, AND THEIR CONJUGATES
  • 批准号:
    6584187
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2002
  • 负责人:
    CHARLES MICHAEL DRAIN
  • 依托单位:
NEW THERAPEUTICS FROM PORPHYRINS, ACETOGENINS, AND THEIR CONJUGATES
  • 批准号:
    6496728
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2001
  • 负责人:
    CHARLES MICHAEL DRAIN
  • 依托单位:
海外基金